Chlorophyllin
Sodium copper chlorophyllin · Liquid chlorophyll
Snapshot
| Indications | Contraindications |
|---|---|
Chlorophyllin is a water-soluble, semisynthetic derivative of chlorophyll, most often sodium copper chlorophyllin, used as a food colorant and over-the-counter product. It is thought to bind carcinogens in the gut and limit their absorption.1 That binding underlies its best-studied use, lowering aflatoxin exposure markers in people with unavoidable dietary exposure and a high risk of liver cancer. It is also used for body and fecal odor in geriatric care, for leukopenia, and as an iron-containing derivative for iron deficiency anemia. Topical gels have been tried for acne and photodamage.
The aflatoxin evidence is a randomized placebo-controlled trial that measured a urinary biomarker, not cancer incidence1, 2. The other uses rest on older, small, or open-label studies and single-center pilots. In 2023, a bioinformatic analysis of shared gene-expression patterns in coronavirus disease 2019 (COVID-19) and tuberculosis flagged chlorophyllin as a candidate compound; no patient trial has tested it for either condition. Products listing chlorophyllin are mostly liquid and capsule forms; see Form comparison.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
35 sources, 23 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.pubmed.ncbi.nlm.nih.govEgner, Wang, Zhu et al. · Proceedings of the National Academy of Sciences of the United States of America · 2001 · Pubmed
- 2Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin.pubmed.ncbi.nlm.nih.govEgner, Muñoz, Kensler · Mutation research · 2003 · Pubmed
- 3Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial.pubmed.ncbi.nlm.nih.govDing, Xu, Jin et al. · Evidence-based complementary and alternative medicine : eCAM · 2019 · Pubmed
- 4Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia.pubmed.ncbi.nlm.nih.govGao, Hu · Chinese journal of integrative medicine · 2005 · Pubmed
- 5Use of chlorophyllin in the care of geriatric patients.pubmed.ncbi.nlm.nih.govYoung, Beregi · Journal of the American Geriatrics Society · 1980 · Pubmed
- 6Pilot Study of Topical Copper Chlorophyllin Complex in Subjects With Facial Acne and Large Pores.pubmed.ncbi.nlm.nih.govStephens, McCook, Herndon · Journal of drugs in dermatology : JDD · 2015 · Pubmed
- 7Assessment of the safety and efficacy of topical copper chlorophyllin in women with photodamaged facial skin.pubmed.ncbi.nlm.nih.govSigler, Stephens · Journal of drugs in dermatology : JDD · 2015 · Pubmed
- 8US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm